Close

연구개발

글로벌 유전자·세포치료제 개발을 선도하는 바이오 혁신기업

파이프라인

Solid Cancers
  • Cytosine deaminase (CD) as a cargo gene
  • Tumor targeting MSCs/CD
  • Local production of 5-FU
  • Cancer cell death by 5-FU
  • Low systemic toxicity
  • Unique therapy during non-treatment period
  • Unveiling cancer-associated neoantigens
  • Phase 0 completed in rGBM
Chronic fibrotic disorders
  • Three genes in one vector for easy manufacturing
  • Activating dormant endogenous stem cells
  • Promoting angiogenesis
  • Reducing fibrosis
  • Rejuvenating damaged organs
  • Functional recovery in a chronic stroke animal model
ISAL (Insertion Site Analysis of Long-Term Repeat)